I listened to that response too, and the way I interpreted it was if there was a hiccup with the FDA or with the enrolled patients/dosing/etc. I think it was the typical, we can't control how life works 100%, so I can't guarantee 100% that the trial will start as soon as expected. I didn't read into it too much either way, but who knows.